Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

Fine-Tuning Process Devised for Gene Therapies

Gene therapy graphic

Researchers designed a technique to adjust the volume of proteins from gene therapy released into patients, providing more control for complex diseases. . . . → Read More: Fine-Tuning Process Devised for Gene Therapies

3-D Printed Scaffold Helps Regrow Soft Tissue

Printed tissue scaffolds

Researchers developed a biodegradable polymer for printed implant scaffolds that in lab rodents maintains its shape to encourage cell and tissue growth. . . . → Read More: 3-D Printed Scaffold Helps Regrow Soft Tissue

GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal

Brain activity graphic

GlaxoSmithKline and biotechnology company Alector Inc. agreed to co-develop two synthetic antibodies for treating neurodegenerative disorders. . . . → Read More: GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal

Microbiome Drug Candidate Licensed in $525M Deal

C. difficile in petri dish

A therapy designed to regenerate healthy gut microbes for treating dangerous intestinal infections is licensed for commercialization to Nestlé Health Science. . . . → Read More: Microbiome Drug Candidate Licensed in $525M Deal

Long-Acting Capsule Helps Reduce Opioid Use

Ambulance at night

A capsule designed to take once a week is shown in animal tests to continuously deliver a craving-reduction drug in that time and suppress opioid intake. . . . → Read More: Long-Acting Capsule Helps Reduce Opioid Use

Plant-Based Material Designed to Replace Plastics

Uses of plant-based material

Biochemists created a polymer film derived from soy proteins in a sustainable process that can replace many of today’s single-use plastics. . . . → Read More: Plant-Based Material Designed to Replace Plastics

U.S. to Buy Covid-19 Antiviral Drug in $1.2B Deal

Capsules

Two U.S. government health agencies agreed to purchase some 1.7 million doses of a Covid-19 antiviral drug, once the drug receives clearance from FDA. . . . → Read More: U.S. to Buy Covid-19 Antiviral Drug in $1.2B Deal

Gene Therapy Company Starts-Up, Gains $200M

Adeno-associated virus

A new company is underway commercializing research on gene therapies for inherited diseases, staked to an initial investment of $200 million. . . . → Read More: Gene Therapy Company Starts-Up, Gains $200M

Biotechs Partner on Gene-Edited Cancer Cell Therapies

Natural killer cell

Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer. . . . → Read More: Biotechs Partner on Gene-Edited Cancer Cell Therapies

AI Gene Therapy Platform Gains $100M in Early Funds

Adeno-associated virus

A company using machine learning to create engineered viruses to deliver gene therapies is raising $100 million in its first venture funding round. . . . → Read More: AI Gene Therapy Platform Gains $100M in Early Funds